EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Visual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study

C A M Bennebroek iD, J van Zwol, M C Montauban van Swijndregt, S E Loudon, A L W Groot, N J C Bauer, J W Pott iD, I C Notting, A J van Sorge, M M van Genderen iD, P de Graaf, A Y N Schouten-van Meeteren und 2 weitere

Acta Ophthalmologica · 2025

DOI: 10.1111/aos.17476 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von C A M Bennebroek und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Optic Nerve Glioma, Visual Fields, Visual Acuity, Vision Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ODAS Stichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To examine long‐term visual impairment and visual field examination (VF) after diverse treatments for paediatric optic pathway glioma (OPG), and to determine prognostic factors for long‐term severe visual impairment or blindness.

Methods

A nationwide retrospective cohort study (1995–2018) was performed on paediatric OPGs that received various (successive) therapies. The analysis of severe VI or blindness was represented by the outcome of both BCVA and VF testing. Prognostic factors for long‐term severe VI or blindness were identified.

Results

Data on BCVA and VF were available in 117 of 136 children (86.0%) who received treatment. After a median follow‐up of 8.3 years (range: 0.1–23.8 years) after the start of treatment, severe VI or blindness (>1.0 LogMAR) was observed in both eyes in 18.8% of 117 patients and in 34.6% of 234 included eyes. This impairment was more common in sporadic OPGs. Monocular VF defects were present in 80.0% of a subgroup of 110 eyes (47.0%), predominantly represented by hemianopia in 69.3% and various scotomas in 28.4%. Independent prognostic factors for severe VI or blindness included starting therapy under the age of 2 years and hypothalamic involvement of the OPG.

Conclusion

In this study, long‐term binocular severe VI or blindness appeared in almost one in five patients and in one in three eyes after diverse treatment for paediatric OPG. Visual field data were available in only one in two children; VF defects were present in four out of five eyes. Children starting therapy under the age of 2 years were particularly at risk for long‐term severe VI or blindness. Future prospective studies need to include VF analysis as an outcome parameter and should analyse treatment effects on both monocular and binocular BCVA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic Nerve GliomaVisual FieldsVisual AcuityVision DisordersOptic Nerve NeoplasmsHumansRetrospective StudiesMaleFemaleChildChild, PreschoolFollow-Up StudiesAdolescentInfantPrognosisVisual Field Tests

Stichwörter der Autor:innen

blindnesschildlow‐grade gliomaoptic pathway gliomatreatmentvisual fieldvisual impairment

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Department of Ophthalmology, Rotterdam, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Ophthalmology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Department of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: C A M Bennebroek, J W Pott, M M van Genderen

Förderung

  • ODAS Stichting

Zitieren

APA

Bennebroek, C. A. M., van Zwol, J., Montauban van Swijndregt, M. C., Loudon, S. E., Groot, A. L. W., Bauer, N. J. C., Pott, J. W., Notting, I. C., van Sorge, A. J., van Genderen, M. M., de Graaf, P., Schouten-van Meeteren, A. Y. N., Saeed, P., & Porro, G. L. (2025). Visual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study. Acta Ophthalmologica. https://doi.org/10.1111/aos.17476

Vancouver

Bennebroek CAM, van Zwol J, Montauban van Swijndregt MC, Loudon SE, Groot ALW, Bauer NJC, et al. Visual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study. Acta Ophthalmologica. 2025. doi:10.1111/aos.17476

BibTeX
@article{Bennebroek2025,
  author = {Bennebroek, C A M and van Zwol, J and Montauban van Swijndregt, M C and Loudon, S E and Groot, A L W and Bauer, N J C and Pott, J W and Notting, I C and van Sorge, A J and van Genderen, M M and de Graaf, P and Schouten-van Meeteren, A Y N and Saeed, P and Porro, G L},
  title = {Visual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study},
  journal = {Acta Ophthalmologica},
  year = {2025},
  doi = {10.1111/aos.17476}
}
Kostenlos starten →